Airsculpt Technologies Stock Today

AIRS Stock  USD 2.65  0.16  5.69%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Airsculpt Technologies is selling for under 2.65 as of the 22nd of March 2025; that is 5.69 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.58. Airsculpt Technologies has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
29th of October 2021
Category
Healthcare
Classification
Health Care
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida. The company has 58.57 M outstanding shares of which 3.06 M shares are presently shorted by private and institutional investors with about 23.41 trading days to cover. More on Airsculpt Technologies

Moving together with Airsculpt Stock

  0.74LNDNF Lundin Energy ABPairCorr

Moving against Airsculpt Stock

  0.87CMRX ChimerixPairCorr
  0.69JNJ Johnson JohnsonPairCorr
  0.68VZ Verizon CommunicationsPairCorr
  0.6T ATT Inc Earnings Call This WeekPairCorr
  0.56NVRO Nevro CorpPairCorr
  0.55BKLRF Berkeley EnergyPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Airsculpt Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President CEOTodd Magazine
Old NameLeverage Shares -3x Short Airbus (AIR.PA) ETP Securities
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Care Facilities, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.520.8588
Way Down
Slightly volatile
Gross Profit Margin0.690.72
Sufficiently Down
Slightly volatile
Net Debt25 M26.4 M
Notably Down
Slightly volatile
Total Current Liabilities19.3 M28.6 M
Way Down
Slightly volatile
Non Current Liabilities Total91.5 M102.1 M
Moderately Down
Slightly volatile
Total Assets213.8 M210 M
Fairly Up
Slightly volatile
Total Current Assets17.8 M17.1 M
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities19.3 M11.3 M
Way Up
Slightly volatile
Debt Levels
Airsculpt Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Airsculpt Technologies' financial leverage. It provides some insight into what part of Airsculpt Technologies' total assets is financed by creditors.
Liquidity
Airsculpt Technologies currently holds 34.6 M in liabilities with Debt to Equity (D/E) ratio of 1.08, which is about average as compared to similar companies. Airsculpt Technologies has a current ratio of 2.2, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Airsculpt Technologies' use of debt, we should always consider it together with its cash and equity.

Other Cashflows From Financing Activities

837,900
Airsculpt Technologies (AIRS) is traded on NASDAQ Exchange in USA. It is located in 1111 Lincoln Road, Miami Beach, FL, United States, 33139 and employs 389 people. Airsculpt Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 154.93 M. Airsculpt Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 58.57 M outstanding shares of which 3.06 M shares are presently shorted by private and institutional investors with about 23.41 trading days to cover. Airsculpt Technologies currently holds about 35.25 M in cash with 11.35 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check Airsculpt Technologies Probability Of Bankruptcy
Ownership Allocation
Airsculpt Technologies holds a total of 58.57 Million outstanding shares. The majority of Airsculpt Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Airsculpt Technologies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Airsculpt Technologies. Please pay attention to any change in the institutional holdings of Airsculpt Technologies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Airsculpt Ownership Details

Airsculpt Stock Institutional Holders

InstituionRecorded OnShares
Morgan Stanley - Brokerage Accounts2024-12-31
74.2 K
Jane Street Group Llc2024-12-31
55.6 K
State Of Wisconsin Investment Board2024-12-31
52.2 K
Tradewinds, Llc.2024-12-31
52.2 K
Jpmorgan Chase & Co2024-12-31
45.8 K
Nuveen Asset Management, Llc2024-12-31
31.2 K
Xtx Topco Ltd2024-12-31
26.5 K
Bank Of New York Mellon Corp2024-12-31
25.5 K
Alliancebernstein L.p.2024-12-31
23.7 K
Vesey Street Capital Partners, L.l.c.2024-12-31
29.3 M
Sw Investment Management Llc2024-12-31
4.7 M
View Airsculpt Technologies Diagnostics

Airsculpt Technologies Historical Income Statement

EBITDA is likely to gain to about 14.2 M in 2025, whereas Tax Provision is likely to drop slightly above 178.6 K in 2025. View More Fundamentals

Airsculpt Stock Against Markets

Airsculpt Technologies Corporate Management

Already Invested in Airsculpt Technologies?

The danger of trading Airsculpt Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Airsculpt Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Airsculpt Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Airsculpt Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Airsculpt Stock Analysis

When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.